Arteris counsel Alpern sells 6,500 shares under plan
The October 2 sales covered tax withholding on restricted stock units released under Arteris’ sell-to-cover election.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Arteris, Inc. (AIP) reported that its VP and General Counsel, Paul L. Alpern, exercised options on October 1, 2026, acquiring 4,000 common shares at $0.56 per share and 2,500 common shares at $9.28 per share. After those exercises, his reported option balances were 45,000 incentive stock options and 22,500 non-qualified stock options.
Alpern also sold 6,500 common shares on October 1 at a weighted average of $23.8359 per share, in multiple transactions priced from $23.41 to $24.15. The exercises and sale were reported as pursuant to a Rule 10b5-1 trading plan adopted February 23, 2026. On October 2, he sold four separate amounts—692, 765, 1,181 and 1,010 shares—each at $24.6431 per share, to satisfy tax liability from released restricted stock units under the issuer’s sell-to-cover requirement; those sales were not discretionary.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F3 | 692 | $24.6431 | $17K |
| Sale | Common Stock F3 | 765 | $24.6431 | $19K |
| Sale | Common Stock F3 | 1,181 | $24.6431 | $29K |
| Sale | Common Stock F3 | 1,010 | $24.6431 | $25K |
| Exercise | Incentive Stock Option (right to buy) F4 | 4,000 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) F5 | 2,500 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 4,000 | $0.56 | $2K |
| Exercise | Common Stock F1 | 2,500 | $9.28 | $23K |
| Sale | Common Stock F1, F2 | 6,500 | $23.8359 | $155K |
Footnotes (5)
- F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on February 23, 2026.
- F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.41 to $24.15 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- F4. Incentive stock option, 25% of the total shares vested on August 26, 2020; thereafter, 1/48th of the total shares vested monthly for 3 years, beginning on September 26, 2020.
- F5. Non-qualified stock options, vesting in 16 equal quarterly installments of 1/16th each, beginning on April 1, 2025.
Key Figures
Key Terms
Rule 10b5-1 trading plan financial
Incentive stock option financial
Non-qualified stock options financial
weighted average sale price financial
restricted stock units financial
sell to cover financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Paul L. Alpern sell on October 1, 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.